Evidence map›Paper›PMID 28874534›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Treg-specific IL-27Rα deletion uncovers a key role for IL-27 in Treg function to control autoimmunity.

Jeongsu Do, Dongkyun Kim, Sohee Kim, Alice Valentin-Torres, Nina Dvorina, Eunjung Jang, Vivekananthan Nagarajavel, Tara M DeSilva, Xiaoxia Li, Angela H Ting and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it, 91 citations in OpenAlex.

  1. Pooled it
  2. Cytokines Associated with Activation of CD4International journal of molecular sciences · 2026
    Review
  3. Review
  4. IL-27 promotes Treg cell expression of CD122 and fitness at homeostasis.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Jeongsu DoDepartment of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195.
Dongkyun KimDepartment of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195.
Sohee KimDepartment of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195.
Alice Valentin-TorresDepartment of Neuroscience, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195.
Nina DvorinaDepartment of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195.
Eunjung JangDepartment of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195.
Vivekananthan NagarajavelGenomic Medicine Institute, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195.
Tara M DeSilvaDepartment of Neuroscience, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195.
Xiaoxia LiDepartment of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195.
Angela H TingGenomic Medicine Institute, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195.
Dario A A VignaliDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261.
Stephen A StohlmanDepartment of Neuroscience, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195.
William M BaldwinDepartment of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195.
Booki MinDepartment of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195; minb@ccf.org.
Cleveland Clinic · USUPMC Hillman Cancer Center · US

Funding

Vascular Cell function and AtherosclerosisP01HL029582 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI FOX, PAUL L · 1985 to 2019
$32.0M
Synergies among inhibitory receptors in tolerance, cancer & antiviral immunityP01AI108545 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI E. John Wherry · 2015 to 2026
$30.8M
The role of IL-27/Lag3 axis in regulating Foxp3+ regulatory T cell functionR01AI125247 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Booki Min · 2017 to 2026
$3.4M
Interleukin-35 and the tumor microenvironmentR01CA203689 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VIGNALI, DARIO AA · 2016 to 2020
$1.9M
Preclinical Study of IL-27-Conditioned Tregs to Treat GvHDR21AI121524 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI HAMILTON, BETTY K, MIN, BOOKI · 2016 to 2017
$436k
NCI NIH HHS R01 CA203689NHLBI NIH HHS P01 HL029582NIAID NIH HHS P01 AI108545NIAID NIH HHS R01 AI125247NIAID NIH HHS R21 AI121524
6 · The paper itself

Abstract

Dysregulated Foxp3

Indexed as

AnimalsAutoimmune DiseasesCentral Nervous SystemDrug Evaluation, PreclinicalEncephalomyelitisForkhead Transcription FactorsInterleukinsMice, TransgenicReceptors, CytokineReceptors, InterleukinT-Lymphocytes, RegulatoryForkhead Transcription FactorsFoxp3 protein, mouseIl27 protein, mouseIl27ra protein, mouseInterleukinsReceptors, CytokineReceptors, InterleukinautoimmunityFoxp3+ regulatory T cellsIL-27Tr1 cells

Identifiers

PMID28874534
PMCPMC5617261
OpenAlexW2753100644

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.